---
title: CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately
  Predict Voriconazole Clearance in Healthy Adults
date: '2023-07-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37505445/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230728180744&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Microdosed midazolam and omeprazole accurately described
  and predicted total CL(VRZ) TRIAL REGISTRATION: EudraCT No: 2020-001017-20, registered
  on March 5th, 2020. DRKS: DRKS00022547, registered on August 6th, ...'
disable_comments: true
---
CONCLUSION: Microdosed midazolam and omeprazole accurately described and predicted total CL(VRZ) TRIAL REGISTRATION: EudraCT No: 2020-001017-20, registered on March 5th, 2020. DRKS: DRKS00022547, registered on August 6th, ...